Three Approved Oral Products, Not One Rybelsus is supplied at 3, 7 and 14 mg
Effects of once-daily oral orforglipron on weight and metabolic markers: a systematic review and meta-analysis of randomized controlled trials
Last updated: March 2026
It minimizes the risk of major cardiovascular events, including heart attack and stroke, by improving weight, blood sugar, and lipid profiles
Molecular Mechanisms of Semaglutide and Liraglutide as a Therapeutic Option for Obesity (April 2024) Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation (May 17, 2025) FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes (December 23, 2024) FDA Approves Weight Management Drug for Patients Aged 12 and Older (June 15, 2021) Victoza (liraglutide) Injection, for Subcutaneous Use
There's another range here (19-22g protein and 190-210 calories)